88614061 - DIRECTMX

Information

• Trademark
• 88614061

• Source

• Serial Number

  88614061

• Registration Number

  6208690

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 40 - Treatment of materials
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  September 12, 2019
  5 years ago

• Registration Date

  December 01, 2020
  4 years ago

• Transaction Date

  December 01, 2020
  4 years ago

• Status Date

  December 01, 2020
  4 years ago

• Published for Opposition Date

  September 15, 2020
  4 years ago

• Location Date

  December 01, 2020
  4 years ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  LE, KHUONG M

• Attorney Docket Number

  512006

  Attorney Name

  Timothy P. Naill

  Law Office Assigned Location Code

  M90

• Owners

  • Salipro Biotech AB

Case File Statements

• GS0011: Biological preparations for use in industry; Biological preparations for use in science; Carriers for biologically active compounds; Biological substances, materials, preparations and elements for scientific and industrial use in vivo and in vitro; Chemical substances, chemical materials and chemical preparations, and natural elements for scientific and industrial use in vivo and in vitro; biological materials for use in industry and science; Chemical substances, materials, preparations and elements for cosmetic preparations; Biological substances, materials, preparations and elements for cosmetic preparations; Lipid nanoparticles for use in industry and science; Lipid nanoparticles comprising protein for use in industry and science; Saposin-lipid nanoparticles for use in industry and science
• GS0051: Biochemical preparations for preventing or treating infectious or parasitic diseases, cancer, diseases of the blood and blood-forming organs, endocrine, nutritional and metabolic diseases, mental and behavioral disorders, diseases of the nervous system, diseases of the eye, diseases of the ear, diseases of the circulatory system, diseases of the respiratory system, diseases of the digestive system, diseases of the skin and subcutaneous tissue, diseases of the musculoskeletal system and connective tissue, diseases of the genitourinary system and autoimmune diseases; Biochemical preparations for preventing or treating infectious or parasitic diseases, cancer, diseases of the blood and blood-forming organs, endocrine, nutritional and metabolic diseases, mental and behavioral disorders, diseases of the nervous system, diseases of the eye, diseases of the ear, diseases of the circulatory system, diseases of the respiratory system, diseases of the digestive system, diseases of the skin and subcutaneous tissue, diseases of the musculoskeletal system and connective tissue, diseases of the genitourinary system and autoimmune diseases in non-human animals; Biological reagents for medical use; Biological reagents for veterinary use; Carriers for pharmaceutical, medical, veterinary or diagnostic compounds; Biochemical preparations for preventing or treating infectious or parasitic diseases, cancer, diseases of the blood and blood-forming organs, endocrine, nutritional and metabolic diseases, mental and behavioral disorders, diseases of the nervous system, diseases of the eye, diseases of the ear, diseases of the circulatory system, diseases of the respiratory system, diseases of the digestive system, diseases of the skin and subcutaneous tissue, diseases of the musculoskeletal system and connective tissue, diseases of the genitourinary system and autoimmune diseases in humans and non-human animals and for use in a diagnostic method; Medicinal preparations and substances for preventing or treating infectious or parasitic diseases, cancer, diseases of the blood and blood-forming organs, endocrine, nutritional and metabolic diseases, mental and behavioral disorders, diseases of the nervous system, diseases of the eye, diseases of the ear, diseases of the circulatory system, diseases of the respiratory system, diseases of the digestive system, diseases of the skin and subcutaneous tissue, diseases of the musculoskeletal system and connective tissue, diseases of the genitourinary system and autoimmune diseases in humans and non-human animals; Veterinary vaccines; Human vaccine preparations; Lipid nanoparticles for medicinal, diagnostic or pharmaceutical purposes; Lipid nanoparticles comprising protein for medical, diagnostic or pharmaceutical purposes; Saposin-lipid nanoparticles for medical, diagnostic or pharmaceutical purposes
• GS0401: Treatment of cells and/or viruses and/or biological membranes to obtain carriers for biologically active, pharmaceutical or diagnostic compounds; Conversion of cells and/or viruses and/or biological membranes into biochemical preparations; Custom manufacturing of lipid nanoparticles in particular of lipid nanoparticles comprising protein or Saposin-lipid nanoparticles; Processing of cells and/or viruses and/or biological membranes for third parties
• GS0421: Biological laboratory services; Biochemistry consultancy; Consulting services in the field of lipid nanoparticles in particular in the field of lipid nanoparticles comprising protein or Saposin-lipid nanoparticles
• PM0001: DIRECT MX

Case File Event Statements

• 12/1/2020 - 4 years ago

  22 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 9/15/2020 - 4 years ago

  21 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 9/15/2020 - 4 years ago

  20 - PUBLISHED FOR OPPOSITION Type: PUBO

• 8/26/2020 - 4 years ago

  19 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 8/9/2020 - 4 years ago

  18 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 8/9/2020 - 4 years ago

  17 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 8/9/2020 - 4 years ago

  16 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 8/9/2020 - 4 years ago

  15 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 8/9/2020 - 4 years ago

  14 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 6/24/2020 - 4 years ago

  13 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3

• 6/24/2020 - 4 years ago

  12 - LETTER OF SUSPENSION E-MAILED Type: GNSL

• 6/24/2020 - 4 years ago

  11 - SUSPENSION LETTER WRITTEN Type: CNSL

• 6/15/2020 - 4 years ago

  10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 6/15/2020 - 4 years ago

  9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 6/15/2020 - 4 years ago

  8 - ASSIGNED TO LIE Type: ALIE

• 6/4/2020 - 4 years ago

  7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 12/19/2019 - 5 years ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 12/19/2019 - 5 years ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 12/19/2019 - 5 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 12/13/2019 - 5 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 9/20/2019 - 5 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS

• 9/16/2019 - 5 years ago

  1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP